|
Media Releases |
Financial Reports |
Presen-tations |
|
04/13/2005
|
|
|
|
| Lonza announces price increase for Niacin and Niacinamide feed grade |
| Continued price increases for raw materials and energy are negatively impacting our chemical business. |
The recent trends are having a considerable impact on our production costs, specifically B3 Vitamins. Therefore, in an effort to help absorb some of these sustained higher costs, Lonza announces increases of 10-12 % which will become effective on June 1, 2005. Demand for Vitamin B3 continues to be strong and it is foreseen that this trend will continue in all market segments. This summer Lonza will inaugurate its second nicotinates plant in China. This additional capacity will allow Lonza to cater to the future increased demand.
Lonza is a life sciences driven company, headquartered in Switzerland, which generated sales of CHF 2.18 billion in 2004. It operates 18 production and R&D facilities in eight countries and employs 5670 people worldwide. Lonza is one of the leading custom manufacturers of chemical intermediates and active ingredients as well as biopharmaceuticals for the pharmaceutical and agrochemical industries. In addition, Lonza offers organic intermediates for a wide range of applications and provides antimicrobial and associated products as well as polymer intermediates and compounds. For more information please visit the company's website at www.lonza.com.
For further information:
Ernesto Plozza
Business Unit Nutrition
Tel +41 61 316 8638
Fax +41 61 316 9638
ernesto.plozza@lonza.com
Werner H. Grauwiler
Corporate Communications
Tel +41 61 316 8361
Fax +41 61 316 9361
werner.grauwiler@lonza.com
|
|
|
